MedTrace Logo

Development of Diagnostic and Treatment Strategy for Resistant Hypertension

NCT03540992 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 780

Last updated 2018-05-30

No results posted yet for this study

Summary

This study is a registry study to examine the clinical features, blood pressure control rate, and clinical prognosis of resistant hypertension in Koreans. This study will register patients with resistance hypertension in eight tertiary hospitals in Korea and follow up them for three years. The prognosis will be analysed according to etiologies, achieved blood pressure, and types of antihypertensive medication.

Conditions

  • Resistant Hypertension

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-14
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03540992 on ClinicalTrials.gov